Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose ketamine versus lidocaine for hemodynamic response during tracheal intubation
IRCT20200825048515N56Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of ketamine and lidocaine (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Blood pressure, Heart rate and 2 more. Started Aug 2022; status: completed.
02
Drugs
ketaminelidocaine
Beyond the preview
Go deeper on IRCT20200825048515N56.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200825048515N56.